Why inventing a vaccine for AIDS is tougher than for COVID

A nurse enrolls a participant in an HIV vaccine trial in Masaka, Uganda, an African-led project.

The 4-decades long effort to create an AIDS vaccine suffered a blow with news that a vaccine in a late stage trial was discontinued because results showed it to be ineffective. What are the obstacles?

(Image credit: Luke Dray/Getty Images)



from News : NPR https://ift.tt/EWP6Ybs

No comments

Powered by Blogger.